Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (194)
  • 2024 (221)
  • 2023 (238)
  • 2022 (166)
  • 2021 (61)
  • 2020 (8)
  • 2019 (2)
  • 2017 (1)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Fake Pills (655)
  • Diversion Division (243)

Drug Name

  • Fentanyl (556)
  • Methamphetamine (250)
  • Cocaine (114)
  • Heroin (103)
  • Oxycodone (66)
  • Opioids (53)
  • Synthetic Opioids (45)
  • Marijuana (Cannabis) (22)
  • Hydromorphone (14)
  • Benzodiazepines (7)
  • Ecstasy/MDMA (7)
  • Morphine (6)
  • Methadone (5)
  • Amphetamines (3)
  • Steroids (3)
  • Ketamine (2)
  • LSD (2)
  • Marijuana Concentrates (1)
  • Psilocybin (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Seattle (222)
  • New England (138)
  • Washington, DC (84)
  • Houston (48)
  • St. Louis (43)
  • El Paso (38)
  • New York (35)
  • Chicago (31)
  • Atlanta (25)
  • Phoenix (25)
  • Miami (24)
  • Rocky Mountain (24)
  • New Jersey (22)
  • Dallas (21)
  • Omaha (21)
  • San Francisco (20)
  • Sede (17)
  • Los Angeles (14)
  • New Orleans (13)
  • Louisville (12)
  • San Diego (12)
  • Detroit (1)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Stratford Man Charged with Distributing Methamphetamine and Oxycodone

Julio 08, 2023
STRATFORD, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration for New England, and Stratford Police Department Chief Joseph McNeil today announced that EDWARD JOHNSON, 31, of Stratford, has been charged by indictment with...
Julio 08, 2023
PRESS RELEASE

Consent Decree Approved Among the U.S. and Cumberland, M.D. based Pharmacy and Pharmacist

Julio 06, 2023
Baltimore, Maryland - U.S. District Judge Lydia K. Griggsby approved the United States’ consent decree with John A. Beckman, a Cumberland, Maryland based pharmacist, and Beckman’s Greene Street Pharmacy, Inc. (“Beckman’s Pharmacy”), resolving the United States’ civil allegations that Beckman and Beckman’s Pharmacy violated the Controlled Substances Act (“CSA”) in...
Julio 06, 2023
PRESS RELEASE

Two Key Players in Arlington, Washington, Drug Ring Sentenced to Prison

Julio 06, 2023
SEATTLE – Two men who served key roles in a large, wide ranging drug distribution conspiracy were sentenced today in U.S. District Court in Seattle to significant prison terms, announced Acting U.S. Attorney Tessa M. Gorman. Aaron Alarcon-Castaneda (aka Sobrino), 38, of Chino, California was sentenced to six years in...
Julio 06, 2023
PRESS RELEASE

Boise Nurse Practitioner and Patient/Medical Assistant Charged with Conspiracy to Distribute Opioids

Junio 30, 2023
BOISE – U.S. Attorney Josh Hurwit announced criminal charges against two defendants today as part of the Department of Justice’s 2023 National Health Care Fraud Enforcement Action. This two-week nationwide law enforcement action resulted in criminal charges against 78 defendants for their alleged participation in health care fraud and opioid...
Junio 30, 2023
PRESS RELEASE

Indictment Charges Alleged Members of Drug Trafficking Organization in Drug, Gun and Money Laundering Charges

Junio 27, 2023
WASHINGTON – This morning, law enforcement agents from the Metropolitan Police Department (MPD), Drug Enforcement Administration (DEA), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), Federal Bureau of Investigation (FBI), and the Internal Revenue Service Criminal Investigation (IRS-CI) arrested 12 alleged members of a violent drug trafficking organization (“DTO”), known...
Junio 27, 2023
PRESS RELEASE

CVS To Pay $70,000 To Resolve Allegations That It Filled Fake Prescriptions

Junio 26, 2023
CONCORD, N.H. – CVS has agreed to pay $70,000 to resolve allegations that it violated the Controlled Substances Act at CVS stores in New Hampshire, U.S. Attorney Jane E. Young announces. “Pharmacies have a legal responsibility to ensure that controlled substances are dispensed only pursuant to valid prescriptions,” said United...
Junio 26, 2023
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

Junio 26, 2023
NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...
Junio 26, 2023
PRESS RELEASE

Three Chinese Chemical Manufacturing Companies and Five Employees Charged with Conspiring to Manufacture Fentanyl

Junio 23, 2023
Brooklyn, NY - Earlier today, at the federal courthouse in Brooklyn, two indictments were unsealed that detail criminal conspiracies by companies and employees based in China to manufacture and distribute fentanyl in the United States. This prosecution is among the first ever in the United States to charge Chinese chemical...
Junio 23, 2023
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

Junio 23, 2023
WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
Junio 23, 2023
PRESS RELEASE

Cheshire Medical Center to Pay $2 Million to Settle Allegations of Controlled Substances Act Violations

Junio 22, 2023
CONCORD, N.H. – U.S. Attorney Jane E. Young announces today that Cheshire Medical Center (CMC) in Keene will pay $2 million to resolve allegations that it violated the Controlled Substances Act (CSA) by failing to keep accurate records of controlled substances, including opioids. “Cheshire Medical Center’s failure to fulfill its...
Junio 22, 2023
Showing 521 - 530 of 891 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 49
  • Página 50
  • Página 51
  • Página 52
  • Current page 53
  • Página 54
  • Página 55
  • Página 56
  • Página 57
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster